Simon Ducheix
Nantes, 44000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Tripartite ER-mitochondria-lipid droplets contact sites control adipocyte metabolic flexibility.
Journal: The EMBO journal
Published: December 12, 2025
Multimodal imaging reveals distinct cardiac benefits of dulaglutide versus dapagliflozin in a mouse model of glucotoxic cardiomyopathy.
Journal: Diabetes, obesity & metabolism
Published: June 28, 2025
From Genetic Findings to new Intestinal Molecular Targets in Lipid Metabolism.
Journal: Current atherosclerosis reports
Published: December 03, 2024
Empagliflozin mitigates metabolic dysfunction-associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetes.
Journal: Diabetes, obesity & metabolism
Published: March 07, 2024
Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma.
Journal: Hepatology communications
Published: April 12, 2022
Lipidomic analysis of adipose-derived extracellular vesicles reveals specific EV lipid sorting informative of the obesity metabolic state.
Journal: Cell reports
Published: August 25, 2021
Seipin localizes at endoplasmic-reticulum-mitochondria contact sites to control mitochondrial calcium import and metabolism in adipocytes.
Journal: Cell reports
Published: June 11, 2021
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure.
Journal: Scientific reports
Published: July 18, 2019
The protective role of liver X receptor (LXR) during fumonisin B1-induced hepatotoxicity.
Journal: Archives of toxicology
Published: August 17, 2018
Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose.
Journal: Frontiers in endocrinology
Published: June 29, 2018
Last Updated: 09/26/2026